Search Protocols under revision. Back New search Go to resultsDiseaseMain groupCross-Sectional, Transplantation, Cellular TherapyHematologic NeoplasmsProtocol groupAcute LeukemiasMyeloproliferative neoplasms (MPN) and myelodysplastic neoplasms (MDS)TransplantationDiseaseAcute Lymphoblastic LeukaemiaAcute Myeloid LeukemiaChronic Myeloid LeukemiaMyelodysplastic NeoplasmsStem Cell Transplantation, AllogeneicSubgroupICD10C91.0-C92.0-C92.1-C92.5-C92.6-C92.7-C92.8-C92.9-C93.0-D46.-MeSHHematopoietic Stem Cell TransplantationPrecursor B-Cell Lymphoblastic Leukemia-LymphomaPrecursor Cell Lymphoblastic Leukemia-LymphomaPrecursor T-Cell Lymphoblastic Leukemia-LymphomaTransplantation ConditioningSequenceChemotherapyChemo-substanceChemo-substanceChemo-substanceChemo-substanceNo. Substances RadiotherapySupportive therapySupportive substanceBalanced Crystalloid SolutionBusulfanCiprofloxacinCotrimoxazoleDexamethasoneEtoposide phosphateFluconazoleFludarabineFosaprepitantGranisetronLevetiracetamThiotepaUrsodeoxycholic acidValaciclovirSupportive substanceBalanced Crystalloid SolutionBusulfanCiprofloxacinCotrimoxazoleDexamethasoneEtoposide phosphateFluconazoleFludarabineFosaprepitantGranisetronLevetiracetamThiotepaUrsodeoxycholic acidValaciclovirSupportive substanceBalanced Crystalloid SolutionBusulfanCiprofloxacinCotrimoxazoleDexamethasoneEtoposide phosphateFluconazoleFludarabineFosaprepitantGranisetronLevetiracetamThiotepaUrsodeoxycholic acidValaciclovirSupportive substanceBalanced Crystalloid SolutionBusulfanCiprofloxacinCotrimoxazoleDexamethasoneEtoposide phosphateFluconazoleFludarabineFosaprepitantGranisetronLevetiracetamThiotepaUrsodeoxycholic acidValaciclovirNo. Substances1013Protocol classificationTherapy classificationcurrent standardIntensityKonditionierung, myeloablativ (MAC)Konditionierung, nicht-myeloablativ (NMA)Therapy indicationTherapy phaseallogene StammzelltransplantationTherapy intentioncurativeRisksEmetogenicity (MASCC/ESMO) only studiesPublicationAuthorBlume KGDi Bartolomeo PKornblit BSolomon SRDiseaseAML, haploidentische StammzelltransplantationAML/ALL/CML, allogene StammzelltransplantationAML/ALL/MDS, allogene SCTAML/MDS, ALL, allogene StammzelltransplantationOriginCity of Hope National Medical Center, California, USAClinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WashingtonDepartment of Hematology, Bone Marrow Transplant Center, Spirito Santo Hospital, Pescara, ItalyThe Blood and Marrow Transplant Program at Northside Hospital, Atlanta, GeorgiaProtokolle in Überarbeitung 4 protocols foundEtoposide Phosphate 60 / TBI 13.2, Allogeneic Stem Cell Transplantation, MAC (PID3221 V1.0)Fludarabine 30 / TBI 12, Allogeneic Stem Cell Transplantation, MAC (PID3219 V1.0)Fludarabine 30 / TBI 2, Allogeneic Stem Cell Transplantation, NMA (PID3222 V1.0)Thiotepa 5 / Busulfan 3.2 / Fludarabine 50, Acute Myeloid Leukemia, Allogeneic Stem Cell Transplantation, RIC (PID1709 V1.0)
